Achieving HCV Elimination in the United States: Progress and Next Steps

In this downloadable slideset, Frederick L. Altice, MD, and Norah Terrault, MD, MPH, review current and emerging trends in the epidemiology of HCV infection in the United States with a focus on what these trends mean for strategies aimed at achieving HCV elimination.

In this downloadable slideset, Jordan J. Feld, MD, MPH, and Natasha Martin, DPhil, review modeling data indicating critical steps needed to achieve HCV elimination targets in the United States: reaching at-risk populations, delivering multiple interventions, and personalizing interventions to optimize outcomes by risk group.

In this downloadable slideset, Jordan J. Feld, MD, MPH, and Natasha Martin, DPhil, review how dramatic changes in the HCV treatment landscape have enabled high cure rates to be safely achieved across a wide range of patient populations, including those previously excluded from HCV therapy because of previous or ongoing injection drug use.

In this downloadable slideset, Frederick L. Altice, MD, and Natasha Martin, DPhil, review the current structural, geographic, and patient-specific barriers to HCV elimination in the United States.

In this downloadable slideset, Alain H. Litwin, MD, and Brianna L. Norton, DO, review the essential roles of primary care physicians in screening, diagnosing, treating, and referring patients infected with HCV to achieve key HCV elimination goals in the United States.

In this downloadable slideset, Jordan J. Feld, MD, MPH, and Norah Terrault, MD, MPH, discuss the evolving roles of hepatologists, gastroenterologists, and infectious disease clinicians in the current HCV treatment landscape and review important strategies that these specialists can take in moving toward the goals of HCV elimination in the United States.